CD19 and B-cell chronic lymphocytic leukemia: Next, we tested the isotype-specific differences of BCRs from 4 TCL1-transgenic mice that spontaneously develop a CD19+CD5+ B cell lymphoproliferative disease (43) that resembles aggressive, treatment-resistant human CLL (44).